| Recruiting | 3 | 1042 | Europe, US, RoW | Involved site radiotherapy, Doxorubicin, Bleomycin, Brentuximab vedotin, Vinblastine, Dacarbazine, Haematopoietic growth factor, Filgrastim, G-CSF, Pegfilgrastim | University College, London, Takeda, University of Miami, European Organisation for Research and Treatment of Cancer - EORTC, Australasian Leukaemia and Lymphoma Group, Seagen Inc., Canadian Cancer Trials Group | Hodgkin Lymphoma | 09/30 | 09/32 | | |
RAINBOW, NCT04061512: Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenström's Macroglobulinaemia |
|
|
| Recruiting | 2/3 | 148 | Europe | Dexamethasone, cyclophosphamide, rituximab, Rituximab, ibrutinib | University College, London, Janssen-Cilag Ltd. | Waldenstrom Macroglobulinemia | 03/30 | 03/30 | | |
